With good reason, there has been growing excitement in the medical community over the increasing availability of real-world evidence and the real-world data that it’s based on. Some have wondered if ...

The fight against cancer is complex and multifaceted, requiring a collective effort to create transformative change. There is a vast opportunity for collaboration to spark discussions and advance ...

The traditional process for evaluating new therapeutics may not generate the evidence that patients, clinicians, and payers need to make real-world decisions. The volume and complexity of information ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. Yet it can be ...

The Supreme Court’s decision to overturn federal protection for abortion changed in an instant how many people think about pregnancy. But it is also changing how health systems need to think about ...

Panelists discuss how RWE informs treatment and safety decisions for special populations such as patients with ECOG PS 2 with metastatic colorectal cancer. Panelists note that patients with ECOG ...

Pragmatic clinical trials are designed to evaluate the effectiveness of interventions under the conditions of routine clinical practice, thereby addressing the gap between traditional randomised ...